Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Epilepsy Behav ; 88: 301-307, 2018 11.
Article in English | MEDLINE | ID: mdl-30342389

ABSTRACT

The imbalance between antioxidant system and reactive oxygen species (ROS) generation is related to epileptogenesis, neuronal death, and seizure frequency. Treatment with vitamin E has been associated with neuroprotection and control of seizures. In most experimental studies, vitamin E treatment has short duration. Therefore, the aim of this study was to verify the role of long-term treatment with vitamin E in rats submitted to the pilocarpine model of epilepsy. Rats were divided into two main groups: control (Ctr) and pilocarpine (Pilo). Each one was subdivided according to treatment: vehicle (Ctr V and Pilo V) or vitamin E at dosages of 6 IU/kg/day (Ctr E6 and Pilo E6) or 60 IU/kg/day (Ctr E60 and Pilo E60). Treatment lasted 120 days from status epilepticus (SE). There were no statistical differences concerning treatment in the Ctr group for all variables, so the data were grouped. Carbonyl content in the hippocampus of Pilo V and Pilo E6 was higher compared with that of the Ctr group (8 ±â€¯1.5, 7.1 ±â€¯1, and 3.1 ±â€¯0.3 nmol carbonyl/mg protein, respectively for Pilo V, Pilo E6, and Ctr; p < 0.05). Carbonyl content was restored to control values in Pilo E60 rats (4.2 ±â€¯1.1 and 3.1 ±â€¯0.3 nmol carbonyl/mg protein, respectively for Pilo E60 and Ctr; p > 0.05). The volume of the hippocampal formation (6.5 ±â€¯0.3, 6.6 ±â€¯0.4, 6.3 ±â€¯0.3, and 7.4 ±â€¯0.2, respectively for Pilo V, Pilo E6, Pilo E60, and Ctr) and subfields CA1 (1.6 ±â€¯0.1, 1.4 ±â€¯0.2, 1.5 ±â€¯0.1, and 2 ±â€¯0.05, respectively for Pilo V, Pilo E6, Pilo E60, and Ctr) and CA3 (1.7 ±â€¯0.1, 1.5 ±â€¯0.2, 1.4 ±â€¯0.1, and 2 ±â€¯0.1, respectively for Pilo V, Pilo E6, Pilo E60, and Ctr) was reduced in the Pilo group regardless of treatment. Parvalbumin immunostaining was increased in the hilus of the Pilo E60 group compared with that in the Ctr group (26 ±â€¯2 and 39.6 ±â€¯8.3 neurons, respectively for Ctr and Pilo E60). No difference was found in seizure frequency and Neo-Timm staining. Therefore, long-term treatment with 60 IU/kg/day of vitamin E prevented oxidative damage in the hippocampus and increased hilar parvalbumin expression in rats with epilepsy without a reduction in seizure frequency.


Subject(s)
Antioxidants/pharmacology , Epilepsy/drug therapy , Oxidative Stress/drug effects , Pilocarpine/metabolism , Seizures/drug therapy , Vitamin E/pharmacology , Analysis of Variance , Animals , Biomarkers/metabolism , Disease Models, Animal , Hippocampus/metabolism , Male , Parvalbumins/metabolism , Rats , Rats, Wistar
2.
Stem Cell Rev Rep ; 7(4): 1006-17, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21503590

ABSTRACT

Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson's disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results.


Subject(s)
Fibroblasts/cytology , Mesenchymal Stem Cells/cytology , Neuroprotective Agents/therapeutic use , Parkinsonian Disorders/pathology , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology , Animals , Brain/metabolism , Brain/pathology , Dopaminergic Neurons/metabolism , Fibroblasts/metabolism , Humans , Immunohistochemistry , Male , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Models, Animal , Parkinsonian Disorders/therapy , Rats , Rats, Wistar , Transplantation, Heterologous , Umbilical Cord/cytology
3.
Arq. neuropsiquiatr ; 68(6): 947-952, Dec. 2010. ilus
Article in English | LILACS | ID: lil-571339

ABSTRACT

Medulloblastoma is a highly malignant primary tumor of the central nervous system. It represents the most frequent type of solid tumor and the leading cause of death related to cancer in early childhood. Current treatment includes surgery, chemotherapy and radiotherapy which may lead to severe cognitive impairment and secondary brain tumors. New perspectives for therapeutic development have emerged with the identification of stem-like cells displaying high tumorigenic potential and increased radio- and chemo-resistance in gliomas. Under the cancer stem cell hypothesis, transformation of neural stem cells and/or granular neuron progenitors of the cerebellum are though to be involved in medulloblastoma development. Dissecting the genetic and molecular alterations associated with this process should significantly impact both basic and applied cancer research. Based on cumulative evidences in the fields of genetics and molecular biology of medulloblastomas, we discuss the possible involvement of developmental signaling pathways as critical biochemical switches determining normal neurogenesis or tumorigenesis. From the clinical viewpoint, modulation of signaling pathways such as TGFβ, regulating neural stem cell proliferation and tumor development, might be attempted as an alternative strategy for future drug development aiming at more efficient therapies and improved clinical outcome of patients with pediatric brain cancers.


Meduloblastoma é um tumor maligno do sistema nervoso central (SNC). Na infância, representa o tumor sólido mais frequente e a principal causa de morte relacionada ao câncer. Tratamentos atuais incluem cirurgia, quimioterapia e radioterapia, que podem trazer prejuízos cognitivos e desenvolvimento de tumores secundários. Novas perspectivas terapêuticas surgem com a identificação de células-tronco em gliomas, as quais apresentam alto potencial tumorigênico e maior resistência à radioterapia e quimioterapia. A hipótese das células-tronco tumorais sugere que a transformação de células-tronco e/ou progenitores neurais do cerebelo está envolvida no desenvolvimento do meduloblastoma. Portanto, analisar alterações genéticas e moleculares envolvidas nesse processo é de grande importância na pesquisa básica e aplicada ao câncer. Nesse sentido, discutimos o possível envolvimento de vias de sinalização bioquímica críticas a ambos os processos de neurogênese normal ou tumorigênese, com base em evidências atuais na área de genética e biologia molecular dos meduloblastomas. Do ponto de vista clínico, a modulação de vias de sinalização como a do TGFβ, regulando proliferação de célula-tronco neural e desenvolvimento tumoral, pode ser uma estratégia alternativa para o desenvolvimento de novos medicamentos objetivando-se terapias mais eficientes e melhora do prognóstico dos pacientes pediátricos com câncer de SNC.


Subject(s)
Humans , Cerebellar Neoplasms/pathology , Medulloblastoma/pathology , Neoplastic Stem Cells/pathology , Neural Stem Cells/pathology , Signal Transduction , Transforming Growth Factor beta , Cerebellar Neoplasms/etiology , Cerebellar Neoplasms/genetics , Medulloblastoma/etiology , Medulloblastoma/genetics , Signal Transduction/genetics , Transforming Growth Factor beta/genetics
4.
BMC Genomics ; 11: 230, 2010 Apr 08.
Article in English | MEDLINE | ID: mdl-20377889

ABSTRACT

BACKGROUND: Uncovering the molecular mechanisms involved in epileptogenesis is critical to better understand the physiopathology of epilepsies and to help develop new therapeutic strategies for this prevalent and severe neurological condition that affects millions of people worldwide. RESULTS: Changes in the transcriptome of hippocampal cells from rats subjected to the pilocarpine model of epilepsy were evaluated by microarrays covering 34,000 transcripts representing all annotated rat genes to date. Using such genome-wide approach, differential expression of nearly 1,400 genes was detected during the course of epileptogenesis, from the early events post status epilepticus (SE) to the onset of recurrent spontaneous seizures. Most of these genes are novel and displayed an up-regulation after SE. Noteworthy, a group of 128 genes was found consistently hyper-expressed throughout epileptogenesis, indicating stable modulation of the p38MAPK, Jak-STAT, PI3K, and mTOR signaling pathways. In particular, up-regulation of genes from the TGF-beta and IGF-1 signaling pathways, with opposite effects on neurogenesis, correlate with the physiopathological changes reported in humans. CONCLUSIONS: A consistent regulation of genes functioning in intracellular signal transduction regulating neurogenesis have been identified during epileptogenesis, some of which with parallel expression patterns reported in patients with epilepsy, strengthening the link between these processes and development of epilepsy. These findings reveal dynamic molecular changes occurring in the hippocampus that may serve as a starting point for designing alternative therapeutic strategies to prevent the development of epilepsy after acquired brain insults.


Subject(s)
Epilepsy/genetics , Hippocampus/chemistry , Animals , Gene Expression , Gene Expression Profiling , Genomics , Hippocampus/metabolism , Male , Pilocarpine/metabolism , Rats , Rats, Wistar , Signal Transduction
5.
Arq Neuropsiquiatr ; 68(6): 947-52, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21243257

ABSTRACT

Medulloblastoma is a highly malignant primary tumor of the central nervous system. It represents the most frequent type of solid tumor and the leading cause of death related to cancer in early childhood. Current treatment includes surgery, chemotherapy and radiotherapy which may lead to severe cognitive impairment and secondary brain tumors. New perspectives for therapeutic development have emerged with the identification of stem-like cells displaying high tumorigenic potential and increased radio- and chemo-resistance in gliomas. Under the cancer stem cell hypothesis, transformation of neural stem cells and/or granular neuron progenitors of the cerebellum are though to be involved in medulloblastoma development. Dissecting the genetic and molecular alterations associated with this process should significantly impact both basic and applied cancer research. Based on cumulative evidences in the fields of genetics and molecular biology of medulloblastomas, we discuss the possible involvement of developmental signaling pathways as critical biochemical switches determining normal neurogenesis or tumorigenesis. From the clinical viewpoint, modulation of signaling pathways such as TGFß, regulating neural stem cell proliferation and tumor development, might be attempted as an alternative strategy for future drug development aiming at more efficient therapies and improved clinical outcome of patients with pediatric brain cancers.


Subject(s)
Cerebellar Neoplasms/pathology , Medulloblastoma/pathology , Neoplastic Stem Cells/pathology , Neural Stem Cells/pathology , Signal Transduction , Transforming Growth Factor beta , Cerebellar Neoplasms/etiology , Cerebellar Neoplasms/genetics , Humans , Medulloblastoma/etiology , Medulloblastoma/genetics , Signal Transduction/genetics , Transforming Growth Factor beta/genetics
6.
J Stem Cells ; 5(3): 103-11, 2010.
Article in English | MEDLINE | ID: mdl-22314826

ABSTRACT

Isolation of highly tumorigenic stem-like cells from human glioblastoma specimens and cell lines has been focusing on their neural stem cells properties or capacity to efflux fluorescent dyes. Here, we report that, under standard culture conditions, human glioblastoma cells of the U87MG cell line display a predominant mesenchymal phenotype and share some of the in vitro properties of mesenchymal stem cells. Moreover, these cells were capable of forming tumors in immunocompetent rats. Infiltrative intracranial tumors could be detected 15 to 30 days post-stereotaxic cell injection within the motor cortex. Tumors were comprised by pleomorphic and mitotically active cells and displayed necrotic and hemorrhagic foci, which are common features of human glioblastomas. This rather unexpected in vivo tumorigenesis in the absence of immune suppression more closely mimics the physiological milieu encountered by tumor cells and could be explored as a xenograft orthotopic model of human glioblastomas to address new therapeutic approaches, particularly those involving immune effector mechanisms.


Subject(s)
Brain Neoplasms/pathology , Glioblastoma/pathology , Immunocompetence , Mesenchymal Stem Cells/pathology , Animals , Cell Differentiation , Cell Shape , Chondrogenesis/physiology , Humans , Immunocompetence/physiology , Male , Mesenchymal Stem Cells/physiology , Neoplasm Transplantation , Osteogenesis/physiology , Rats , Rats, Wistar , Transplantation, Heterologous , Tumor Cells, Cultured
7.
Brain Res Bull ; 76(5): 480-4, 2008 Jul 30.
Article in English | MEDLINE | ID: mdl-18534255

ABSTRACT

Vitamin D (VD), is a steroid hormone with multiple functions in the central nervous system (CNS), producing numerous physiological effects mediated by its receptor (VDR). Clinical and experimental studies have shown a link between VD dysfunction and epilepsy. Along these lines, the purpose of our work was to analyze the relative expression of VDR mRNA in the hippocampal formation of rats during the three periods of pilocarpine-induced epilepsy. Male Wistar rats were divided into five groups: (1) control group; rats that received saline 0.9%, i.p. and were killed 7 days after its administration (CTRL, n=8), (2) SE group; rats that received pilocarpine and were killed 4h after SE (SE, n=8), (3) Silent group--7 days; rats that received pilocarpine and were killed 7 days after SE (SIL 7d, n=8), (4) Silent group--14 days; rats that received pilocarpine and were killed 14 days after SE (SIL 14d, n=8), (5) Chronic group; rats that received pilocarpine and were killed 60 days after the first spontaneous seizure, (chronic, n=8). The relative expression of VDR mRNA was determined by real-time PCR. Our results showed an increase of the relative expression of VDR mRNA in the SIL 7 days, SIL 14 days and Chronic groups, respectively (0.060+/-0.024; 0.052+/-0.035; 0.085+/-0.055) when compared with the CTRL and SE groups (0.019+/-0.017; 0.019+/-0.025). These data suggest the VDR as a possible candidate participating in the epileptogenesis process of the pilocarpine model of epilepsy.


Subject(s)
Epilepsy, Temporal Lobe/chemically induced , Hippocampus , Muscarinic Agonists/pharmacology , Pilocarpine/pharmacology , RNA, Messenger/metabolism , Receptors, Calcitriol/metabolism , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Epilepsy, Temporal Lobe/metabolism , Gene Expression/drug effects , Hippocampus/drug effects , Hippocampus/metabolism , Humans , Male , Rats , Rats, Wistar , Receptors, Calcitriol/genetics
8.
Einstein (Säo Paulo) ; 6(1): 93-96, 2008.
Article in Portuguese | LILACS | ID: lil-497754

ABSTRACT

Distúrbios no processo de neurogênese têm sido correlacionados com diferentes patologias, como doenças neurodegenerativas, epilepsia, síndrome de Down e depressão. Nessa revisão, discute se o envolvimento de células-tronco neurais e neuroprogenitores ao longo do desenvolvimento e maturação do sistema nervoso. São destacadas a relevância dessas células ao funcionamento do sistema nervoso central nos contextos fisiológico e patológico, bem como novas estratégias terapêuticas baseadas na modulação da neurogênese pós-natal.


Subject(s)
Cell- and Tissue-Based Therapy , Neurons/cytology , Stem Cells , Central Nervous System/cytology , Central Nervous System/physiology
9.
Brain Res Bull ; 74(4): 216-20, 2007 Sep 28.
Article in English | MEDLINE | ID: mdl-17720542

ABSTRACT

Several studies have demonstrated the anticonvulsant effect of melatonin. In view of the positive effects of physical exercise in epilepsy, this study analyzed the influence of physical exercise program on the amygdala kindling development in pinealectomized rats. Animals were divided into six groups: pinealectomized rats (PX), sham rats (SHAM), control rats (CTL), pinealectomized rats submitted to an aerobic exercise program (PX ATL), sham rats submitted to an aerobic exercise program (SHAM ATL) and control rats submitted to an aerobic exercise program (CTL ATL). The stimulus parameters consisted of 60 Hz frequency, diphasic square pulses of 1 ms duration applied for 2 s. The mean number of stimulations and the after-discharge (AD) duration for each stage of kindling were similar among CTL and SHAM animals. PX animals showed particular characteristics during kindling development. They did not present stage 1 and spent a shorter time in stage 2 in relation to the CTL and SHAM animals. Consequently, the AD duration and number of stimulations required to reach stage 5 was lower for the PX group when compared to the CTL and SHAM groups. Concerning the exercising groups, CTL ATL and SHAM ATL animals spent a higher time in stage 1 compared to CTL and SHAM groups. Thus, CTL ATL animals also presented a higher number of stimulations in stage 5 compared to CTL animals. The stage 1 not observed in PX animals was present in PX ATL. Consequently, the number of stimulations required to reach stage 5 was statistically higher for the PX ATL group in relation to the PX group. Our results demonstrate that the acceleration in the kindling development of pinealectomized animals can be reverted by physical exercise.


Subject(s)
Amygdala/physiopathology , Kindling, Neurologic/physiology , Physical Conditioning, Animal/methods , Pineal Gland/surgery , Analysis of Variance , Animals , Behavior, Animal , Electric Stimulation/adverse effects , Male , Rats , Rats, Wistar , Time Factors
10.
Einstein (Säo Paulo) ; 5(4): 387-391, 2007.
Article in Portuguese | LILACS | ID: lil-485808

ABSTRACT

Modelos experimentais animais têm sido fundamentais para o avançodo conhecimento a respeito da fisiopatologia da doença de Parkinson,bem como ao desenvolvimento de novas abordagens terapêuticasbaseadas em processos intrínsecos à sua patogênese. Entre as novasestratégias terapêuticas atualmente em experimentação, destacam-seas baseadas em processos neurorrestauradores pelo transplante comcélulas-tronco neurais e/ou neuroprogenitores fetais. Embora estudospré-clínicos demonstrem efeitos positivos com relação à reposiçãode neurônios dopaminérgicos, preservação de circuitária neuronal e amenização de sintomas clínicos, principalmente os motores, questõesfundamentais ainda persistem e devem ser pesquisadas antes que aterapia celular se consolide como alternativa ao tratamento da doençade Parkinson. Além da reposição de neurônios dopaminérgicos,a manipulação do microambiente celular e a mobilização deneuroprogenitores endógenos surgem como alternativas a seremexploradas. Em relação à segurança desses procedimentos, estudosde longo prazo em modelos animais são importantes e devem serrealizados para acessar eventuais distúrbios motores, cognitivos ecomportamentais, bem como a possibilidade de desenvolvimentode tumores.


Subject(s)
Humans , Male , Female , Cell- and Tissue-Based Therapy , Parkinson Disease , Stem Cells
11.
Neurosci Lett ; 392(1-2): 150-3, 2006 Jan 09.
Article in English | MEDLINE | ID: mdl-16183197

ABSTRACT

A considerable number of studies have demonstrated the anticonvulsant effect of melatonin. The present study examines the influence of pinealectomy on the amygdala kindling development in rats. Animals were divided into three groups: Pinealectomized rats (PNT) Sham rats (SHAM) and Control rats (CTL). The mean number of stimulations and the afterdischarge (AD) duration for each stage of kindling were similar among CTL and SHAM animals. Conversely, PNT animals showed particular characteristics during kindling development. They did not present stage 1 and spent a shorter time in stage 2 in relation to the CTL and SHAM animals. Consequently, the number of stimulations required to reach stage 5 was lower for the PNT group when compared to the CTL and SHAM groups. Besides, a longer AD duration during stage 5 in the PNT group was also observed. The present findings indicate that the pineal gland removal exert a significant influence on amygdala kindling development suggesting that melatonin holds potential interest in experimental therapy for epilepsy.


Subject(s)
Amygdala/physiopathology , Kindling, Neurologic/physiology , Pineal Gland/surgery , Animals , Behavior, Animal/drug effects , Electric Stimulation/methods , Male , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...